US Stock MarketDetailed Quotes
PLX Protalix Biotherapeutics
- 1.690
- +0.010+0.60%
Close Nov 27 16:00 ET
- 1.730
- +0.040+2.36%
Post 20:01 ET
124.44MMarket Cap-11266P/E (TTM)
1.730High1.680Low174.49KVolume1.700Open1.680Pre Close296.65KTurnover0.32%Turnover Ratio18.78P/E (Static)73.63MShares1.90052wk High3.83P/B92.53MFloat Cap0.82152wk Low--Dividend TTM54.75MShs Float1037.500Historical High--Div YieldTTM2.98%Amplitude0.700Historical Low1.700Avg Price1Lot Size
About Protalix Biotherapeutics Company
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.
Company Profile
SymbolPLX
Company NameProtalix Biotherapeutics
Listing DateApr 9, 1996
Issue Price6.00
Founded1993
CEOMr. Dror Bashan
MarketAMEX
Employees208
Fiscal Year Ends12-31
Address2 University Plaza,Suite 100
CityHackensack
ProvinceNew Jersey
CountryUnited States of America
Zip Code07601
Websitehttp://www.protalix.com
Company Executives
- Name
- Position
- Salary
- Dror Bashan
- Director, President and Chief Executive Officer
- 2.68M
- Eyal Rubin
- Senior Vice President, Chief Financial Officer, Treasurer, Secretary and Principal Accounting Officer
- 1.03M
- Yaron Naos
- Senior Vice President, Operations
- 776.37K
- Dr. Eliot Richard Forster, M.B.A.,PhD
- Chairman of the Board
- 47.99K
- Gwen A. Melincoff
- Independent Director
- 79.91K
- Amos Bar Shalev
- Independent Director
- 79.91K
- Dr. Shmuel Ben-Zvi, PhD
- Independent Director
- 74.71K
- Dr. Aharon Schwartz,PhD
- Independent Director
- 79.91K
- Dr. Pol F. Boudes,M.D.
- Independent Director
- 115.39K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data